FXR activation inhibits inflammation and preserves the intestinal barrier in IBD

Gut. 2011 Apr;60(4):432-3. doi: 10.1136/gut.2010.233304. Epub 2011 Jan 26.
No abstract available

Publication types

  • Comment

MeSH terms

  • Animals
  • Disease Models, Animal
  • Gastrointestinal Agents / therapeutic use
  • Humans
  • Inflammatory Bowel Diseases / drug therapy
  • Inflammatory Bowel Diseases / physiopathology*
  • Intestinal Absorption / physiology*
  • Mice
  • Receptors, Cytoplasmic and Nuclear / agonists
  • Receptors, Cytoplasmic and Nuclear / physiology*

Substances

  • Gastrointestinal Agents
  • Receptors, Cytoplasmic and Nuclear
  • farnesoid X-activated receptor